mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.009 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |